Search

Author/Creator Stockholm, Daniel

2. Natural history of LGMD2A for delineating outcome measures in clinical trials. Issue 4 (4th March 2016)

Authors:
Richard, Isabelle; Hogrel, Jean‐Yves; Stockholm, Daniel; Payan, Christine A. M.; Fougerousse, Françoise; Eymard, Bruno; Mignard, Claude; Lopez de Munain, Adolfo; Fardeau, Michel; Urtizberea, Jon Andoni
Journal:
Annals of clinical and translational neurology
Issue:
Volume 3:Issue 4(2016)
Page Start:
248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The intestinal quorum sensing 3-oxo-C12:2 Acyl homoserine lactone limits cytokine-induced tight junction disruption. Issue 4 (1st October 2020)

Authors:
Aguanno, Doriane; Coquant, Garance; Postal, Barbara G.; Osinski, Céline; Wieckowski, Margaux; Stockholm, Daniel; Grill, Jean-Pierre; Carrière, Véronique; Seksik, Philippe; Thenet, Sophie
Journal:
Tissue barriers
Issue:
Volume 8:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles. (December 2017)

Authors:
Vermeer, Louic S.; Hamon, Loic; Schirer, Alicia; Schoup, Michel; Cosette, Jérémie; Majdoul, Saliha; Pastré, David; Stockholm, Daniel; Holic, Nathalie; Hellwig, Petra; Galy, Anne; Fenard, David; Bechinger, Burkhard
Journal:
Acta biomaterialia
Issue:
Volume 64(2017)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗